November 3, 2025
The Billion-Dollar Biology of Oncology: What Really Drives Pharma’s Appetite?
By Jonathan Tobin, Partner – Brandon Capital Plenty is written about the trends in dollars and modalities being invested in oncology by VCs. But equally important are the exits, and for early-stage investors M&A is especially important. Exits fuel our…
